Magnesium’s Surprising Effect on Blood Sugar

In this brief monologue, Brigid Titgemeier highlights a body of research examining magnesium supplementation as a strategy for improving blood sugar control. She references a meta‑analysis of multiple clinical trials lasting 1–6 months, involving adults aged 30–64 of both sexes. The analysis found that long‑term magnesium intake produced a small but statistically significant reduction in fasting insulin levels and enhanced insulin sensitivity, but these benefits were pronounced primarily in participants who were at risk for, or already diagnosed with, diabetes. In contrast, individuals without diabetes did not experience notable insulin reductions. The overall message is that magnesium may be a modest adjunct for glycemic management in at‑risk populations.










